| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 6.05e-05 | 11 | 146 | 3 | GO:0005388 | |
| Domain | Aa_trans | 8.32e-06 | 17 | 148 | 4 | PF01490 | |
| Domain | AA_transpt_TM | 8.32e-06 | 17 | 148 | 4 | IPR013057 | |
| Domain | L27_2 | 6.24e-05 | 2 | 148 | 2 | PF09045 | |
| Domain | L27_2 | 6.24e-05 | 2 | 148 | 2 | IPR015132 | |
| Domain | ARM-type_fold | DOCK2 NBEAL1 INTS1 CUL9 RICTOR APOB ARMCX5 RSPRY1 DOCK5 NUP188 TNPO3 | 8.38e-05 | 339 | 148 | 11 | IPR016024 |
| Domain | IG | IGFN1 SLAMF9 OSCAR OBSCN BTN3A1 CNTN6 FCRL1 HMCN2 LRIG1 VCAN ROBO2 IGSF3 | 1.36e-04 | 421 | 148 | 12 | SM00409 |
| Domain | Ig_sub | IGFN1 SLAMF9 OSCAR OBSCN BTN3A1 CNTN6 FCRL1 HMCN2 LRIG1 VCAN ROBO2 IGSF3 | 1.36e-04 | 421 | 148 | 12 | IPR003599 |
| Domain | ATPase_dyneun-rel_AAA | 1.66e-04 | 14 | 148 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.66e-04 | 14 | 148 | 3 | PF07728 | |
| Domain | Cation_ATPase_N | 3.65e-04 | 18 | 148 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 3.65e-04 | 18 | 148 | 3 | SM00831 | |
| Domain | DUF2476 | 3.70e-04 | 4 | 148 | 2 | PF10630 | |
| Domain | PRR23 | 3.70e-04 | 4 | 148 | 2 | IPR018903 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.30e-04 | 19 | 148 | 3 | IPR004014 | |
| Domain | Ig-like_fold | IGFN1 SLAMF9 OSCAR OBSCN PLXNB2 BTN3A1 CNTN6 FCRL1 HMCN2 LRIG1 PTPRJ VCAN ROBO2 EPHA1 IGSF3 | 4.95e-04 | 706 | 148 | 15 | IPR013783 |
| Domain | IG_LIKE | IGFN1 SLAMF9 OSCAR OBSCN BTN3A1 CNTN6 FCRL1 HMCN2 LRIG1 VCAN ROBO2 IGSF3 | 5.49e-04 | 491 | 148 | 12 | PS50835 |
| Domain | IGc2 | 5.80e-04 | 235 | 148 | 8 | SM00408 | |
| Domain | Ig_sub2 | 5.80e-04 | 235 | 148 | 8 | IPR003598 | |
| Domain | DOCK_N | 6.14e-04 | 5 | 148 | 2 | PF16172 | |
| Domain | DOCK_N | 6.14e-04 | 5 | 148 | 2 | IPR032376 | |
| Domain | LNR | 6.14e-04 | 5 | 148 | 2 | PS50258 | |
| Domain | Ig-like_dom | IGFN1 SLAMF9 OSCAR OBSCN BTN3A1 CNTN6 FCRL1 HMCN2 LRIG1 VCAN ROBO2 IGSF3 | 6.78e-04 | 503 | 148 | 12 | IPR007110 |
| Domain | Ig_I-set | 8.08e-04 | 190 | 148 | 7 | IPR013098 | |
| Domain | I-set | 8.08e-04 | 190 | 148 | 7 | PF07679 | |
| Domain | - | IGFN1 SLAMF9 OSCAR OBSCN PLXNB2 BTN3A1 CNTN6 FCRL1 LRIG1 PTPRJ VCAN ROBO2 EPHA1 IGSF3 | 8.12e-04 | 663 | 148 | 14 | 2.60.40.10 |
| Domain | ASX_HYDROXYL | 1.20e-03 | 100 | 148 | 5 | PS00010 | |
| Domain | S04_transporter_CS | 1.28e-03 | 7 | 148 | 2 | IPR018045 | |
| Domain | Notch_dom | 1.28e-03 | 7 | 148 | 2 | IPR000800 | |
| Domain | Notch | 1.28e-03 | 7 | 148 | 2 | PF00066 | |
| Domain | NL | 1.28e-03 | 7 | 148 | 2 | SM00004 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.56e-03 | 106 | 148 | 5 | IPR000152 | |
| Domain | fn3 | 1.86e-03 | 162 | 148 | 6 | PF00041 | |
| Domain | SLC26A | 2.69e-03 | 10 | 148 | 2 | PS01130 | |
| Domain | ATPase_P-typ_P_site | 2.87e-03 | 36 | 148 | 3 | IPR018303 | |
| Domain | P_typ_ATPase | 2.87e-03 | 36 | 148 | 3 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.87e-03 | 36 | 148 | 3 | PS00154 | |
| Domain | EGF_CA | 2.88e-03 | 122 | 148 | 5 | SM00179 | |
| Domain | IGv | 2.98e-03 | 75 | 148 | 4 | SM00406 | |
| Domain | EGF-like_Ca-bd_dom | 3.09e-03 | 124 | 148 | 5 | IPR001881 | |
| Domain | ATPase_P-typ_transduc_dom_A | 3.11e-03 | 37 | 148 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 3.11e-03 | 37 | 148 | 3 | PF00122 | |
| Domain | STAS | 3.27e-03 | 11 | 148 | 2 | PS50801 | |
| Domain | STAS | 3.27e-03 | 11 | 148 | 2 | PF01740 | |
| Domain | SLC26A/SulP_fam | 3.27e-03 | 11 | 148 | 2 | IPR001902 | |
| Domain | DHR-1_domain | 3.27e-03 | 11 | 148 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.27e-03 | 11 | 148 | 2 | PS51651 | |
| Domain | DHR_1 | 3.27e-03 | 11 | 148 | 2 | PS51650 | |
| Domain | DHR-2 | 3.27e-03 | 11 | 148 | 2 | PF06920 | |
| Domain | DOCK | 3.27e-03 | 11 | 148 | 2 | IPR026791 | |
| Domain | STAS_dom | 3.27e-03 | 11 | 148 | 2 | IPR002645 | |
| Domain | SLC26A/SulP_dom | 3.27e-03 | 11 | 148 | 2 | IPR011547 | |
| Domain | DOCK_C | 3.27e-03 | 11 | 148 | 2 | IPR010703 | |
| Domain | DOCK-C2 | 3.27e-03 | 11 | 148 | 2 | PF14429 | |
| Domain | DHR-2 | 3.27e-03 | 11 | 148 | 2 | IPR027357 | |
| Domain | - | 3.27e-03 | 11 | 148 | 2 | 3.30.750.24 | |
| Domain | Sulfate_transp | 3.27e-03 | 11 | 148 | 2 | PF00916 | |
| Domain | FN3 | 3.60e-03 | 185 | 148 | 6 | SM00060 | |
| Domain | Laminin_G_2 | 3.89e-03 | 40 | 148 | 3 | PF02210 | |
| Domain | L27 | 4.59e-03 | 13 | 148 | 2 | SM00569 | |
| Domain | L27 | 4.59e-03 | 13 | 148 | 2 | PS51022 | |
| Domain | L27_dom | 4.59e-03 | 13 | 148 | 2 | IPR004172 | |
| Domain | LamG | 5.09e-03 | 44 | 148 | 3 | SM00282 | |
| Domain | FN3 | 5.12e-03 | 199 | 148 | 6 | PS50853 | |
| Domain | Ig_V-set | 5.12e-03 | 199 | 148 | 6 | IPR013106 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.33e-03 | 14 | 148 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.33e-03 | 14 | 148 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.33e-03 | 14 | 148 | 2 | IPR013602 | |
| Domain | Znf_UBP | 5.33e-03 | 14 | 148 | 2 | IPR001607 | |
| Domain | DHC_N2 | 5.33e-03 | 14 | 148 | 2 | PF08393 | |
| Domain | zf-UBP | 5.33e-03 | 14 | 148 | 2 | PF02148 | |
| Domain | MT | 5.33e-03 | 14 | 148 | 2 | PF12777 | |
| Domain | AAA_8 | 5.33e-03 | 14 | 148 | 2 | PF12780 | |
| Domain | ZF_UBP | 5.33e-03 | 14 | 148 | 2 | PS50271 | |
| Domain | DHC_fam | 6.12e-03 | 15 | 148 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.12e-03 | 15 | 148 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.12e-03 | 15 | 148 | 2 | IPR004273 | |
| Domain | FN3_dom | 6.47e-03 | 209 | 148 | 6 | IPR003961 | |
| Domain | - | 6.90e-03 | 95 | 148 | 4 | 2.60.120.200 | |
| Domain | Nicotinic_acetylcholine_rcpt | 6.96e-03 | 16 | 148 | 2 | IPR002394 | |
| Domain | ATPase_P-typ_TM_dom | 6.96e-03 | 16 | 148 | 2 | IPR023298 | |
| Domain | - | 6.96e-03 | 16 | 148 | 2 | 1.20.1110.10 | |
| Domain | EGF_Ca-bd_CS | 7.42e-03 | 97 | 148 | 4 | IPR018097 | |
| Domain | ATPase_P-typ_cation-transptr_C | 7.85e-03 | 17 | 148 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 7.85e-03 | 17 | 148 | 2 | PF00689 | |
| Domain | Peptidase_aspartic_dom | 7.85e-03 | 17 | 148 | 2 | IPR021109 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 9.60e-06 | 6 | 112 | 3 | MM14679 | |
| Pathway | REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS | 9.60e-06 | 6 | 112 | 3 | M27027 | |
| Pubmed | 3.96e-07 | 214 | 149 | 9 | 22199357 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TAPT1 DYNC2H1 SLC26A2 INTS1 MTFP1 APOB TNFRSF10D NPLOC4 TBC1D8 DOCK5 SETD2 MDN1 CELSR2 PTPRJ NUP188 PCCB PIGO NOTCH3 | 7.43e-07 | 1061 | 149 | 18 | 33845483 |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SLC26A2 RICTOR APOB DOCK5 CELSR2 PTPRJ CSPG4 PATJ USP6NL VPS13B EPHA1 IGSF3 | 6.82e-06 | 569 | 149 | 12 | 30639242 |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 9.58e-06 | 171 | 149 | 7 | 20201926 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 17900358 | ||
| Pubmed | Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. | 1.82e-05 | 2 | 149 | 2 | 15609081 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 11558903 | ||
| Pubmed | Rare novel CYP2U1 and ZFYVE26 variants identified in two Pakistani families with spastic paraplegia. | 1.82e-05 | 2 | 149 | 2 | 32006740 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 25339677 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31645658 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 29955124 | ||
| Pubmed | PATJ and MPDZ are required for trophectoderm lineage specification in early mouse embryos. | 1.82e-05 | 2 | 149 | 2 | 37318097 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 36932261 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 12121305 | ||
| Pubmed | Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens. | 1.82e-05 | 2 | 149 | 2 | 36411381 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 22212222 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 16625365 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ALKBH4 BCAS3 INTS1 OBSCN CUL9 PLXNB2 TAOK2 MDN1 CELSR2 CSPG4 ZFYVE26 NUP188 ENDOG DHX34 TNPO3 IGSF3 | 2.28e-05 | 1105 | 149 | 16 | 35748872 |
| Pubmed | 3.38e-05 | 15 | 149 | 3 | 23506890 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 27138255 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 25375884 | ||
| Pubmed | Organization and expression of the SLC36 cluster of amino acid transporter genes. | 5.45e-05 | 3 | 149 | 2 | 15058382 | |
| Pubmed | A cluster of proton/amino acid transporter genes in the human and mouse genomes. | 5.45e-05 | 3 | 149 | 2 | 12809675 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 28323982 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 12403818 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 10967549 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 23531444 | ||
| Pubmed | CHRNA2 mutations are rare in the NFLE population: evaluation of a large cohort of Italian patients. | 5.45e-05 | 3 | 149 | 2 | 18226955 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 24913231 | ||
| Pubmed | DOCK2 regulates MRGPRX2/B2-mediated mast cell degranulation and drug-induced anaphylaxis. | 5.45e-05 | 3 | 149 | 2 | 36804596 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 10036240 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 19058950 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 18991851 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 19255144 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 18028994 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | 5.71e-05 | 307 | 149 | 8 | 37499664 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | LARGE2 GNPTAB PLXNB2 USP5 SERPINI1 MIA2 CELSR2 PTPRJ CSPG4 GM2A CERCAM NGLY1 PIGO NOTCH3 SMAD2 IGSF3 | 6.13e-05 | 1201 | 149 | 16 | 35696571 |
| Pubmed | 6.70e-05 | 405 | 149 | 9 | 38187761 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BCAS3 OBSCN STAP2 LARP4 ADCY3 NPLOC4 ITPK1 DNAH1 DOCK5 ATP2C1 KCNQ5 PTPRJ EIF2B4 TJAP1 SCAF11 PATJ VPS13B NOTCH3 | 7.27e-05 | 1489 | 149 | 18 | 28611215 |
| Pubmed | 9.63e-05 | 331 | 149 | 8 | 20634891 | ||
| Pubmed | CUL9 BPIFB1 FANCC ATP2C1 MDN1 SCUBE2 SCAF11 NUP188 TNPO3 TOP2B HDLBP | 9.67e-05 | 634 | 149 | 11 | 34591612 | |
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 26147384 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 15826950 | ||
| Pubmed | TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. | 1.09e-04 | 4 | 149 | 2 | 19966281 | |
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 24220035 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 26055322 | ||
| Pubmed | 1.65e-04 | 25 | 149 | 3 | 21145499 | ||
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 24365888 | ||
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 36423520 | ||
| Pubmed | LDL-cholesterol concentrations: a genome-wide association study. | 1.81e-04 | 5 | 149 | 2 | 18262040 | |
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 19286658 | ||
| Pubmed | The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways. | 1.81e-04 | 5 | 149 | 2 | 28747678 | |
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 12495930 | ||
| Pubmed | Expression of NG2 proteoglycan during endochondral and intramembranous ossification. | 1.81e-04 | 5 | 149 | 2 | 12950088 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 2.34e-04 | 377 | 149 | 8 | 38117590 | |
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 24788939 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 17397395 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 15713213 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 10095079 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 11087667 | ||
| Pubmed | 2.87e-04 | 30 | 149 | 3 | 19936222 | ||
| Pubmed | CRISP2 USP45 COL11A2 DSP TENT5A BTN3A1 VPS52 MDN1 KCNQ5 TJAP1 | 3.69e-04 | 622 | 149 | 10 | 14574404 | |
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 15599946 | ||
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 16885194 | ||
| Pubmed | Chromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans. | 3.78e-04 | 7 | 149 | 2 | 1505988 | |
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 20231857 | ||
| Pubmed | Genome-wide association study of smoking behaviours among Bangladeshi adults. | 4.18e-04 | 34 | 149 | 3 | 24665060 | |
| Pubmed | 4.42e-04 | 147 | 149 | 5 | 29576527 | ||
| Pubmed | Newly identified loci that influence lipid concentrations and risk of coronary artery disease. | 4.56e-04 | 35 | 149 | 3 | 18193043 | |
| Pubmed | 4.84e-04 | 529 | 149 | 9 | 14621295 | ||
| Pubmed | Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice. | 5.00e-04 | 85 | 149 | 4 | 25131634 | |
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 17559419 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 34124060 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 23233679 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 21041365 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 20096780 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 10951186 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 29155075 | ||
| Pubmed | MPDZ RICTOR NR3C1 PAPSS2 NPLOC4 RSPRY1 DOCK5 FREM2 PATJ DHX34 | 5.19e-04 | 650 | 149 | 10 | 38777146 | |
| Pubmed | Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing. | 5.38e-04 | 37 | 149 | 3 | 20843780 | |
| Pubmed | 5.67e-04 | 329 | 149 | 7 | 17474147 | ||
| Pubmed | Physiological roles and regulation of mammalian sulfate transporters. | 6.44e-04 | 9 | 149 | 2 | 11581495 | |
| Pubmed | 6.44e-04 | 9 | 149 | 2 | 8906617 | ||
| Pubmed | Placental, renal, and ileal sulfate transporter gene expression in mouse gestation. | 6.44e-04 | 9 | 149 | 2 | 22674389 | |
| Pubmed | 6.44e-04 | 9 | 149 | 2 | 19228980 | ||
| Pubmed | Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleus. | 6.44e-04 | 9 | 149 | 2 | 15004035 | |
| Pubmed | 6.44e-04 | 9 | 149 | 2 | 20723208 | ||
| Pubmed | Sources of energy for gating by neurotransmitters in acetylcholine receptor channels. | 6.44e-04 | 9 | 149 | 2 | 22647603 | |
| Pubmed | 6.44e-04 | 9 | 149 | 2 | 20370913 | ||
| Pubmed | Locations of human and mouse genes encoding the RFX1 and RFX2 transcription factor proteins. | 6.44e-04 | 9 | 149 | 2 | 8661125 | |
| Pubmed | 6.87e-04 | 162 | 149 | 5 | 25826454 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DSP INTS1 RFX1 PLXNB2 RSPRY1 VPS52 ATP2C1 MIA2 CSPG4 NUP188 TNPO3 USP6NL TOP2B IGSF3 | 6.94e-04 | 1203 | 149 | 14 | 29180619 |
| Pubmed | 7.88e-04 | 167 | 149 | 5 | 22159717 | ||
| Pubmed | BTBD8 NBEAL1 BCAS3 SLCO3A1 CUL9 XDH RICTOR TMEM132D ASPRV1 PATJ USP6NL | 8.02e-04 | 814 | 149 | 11 | 23251661 | |
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 20736995 | ||
| Pubmed | A piggyBac insertion disrupts Foxl2 expression that mimics BPES syndrome in mice. | 8.02e-04 | 10 | 149 | 2 | 24565867 | |
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 19139271 | ||
| Pubmed | N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. | 8.02e-04 | 10 | 149 | 2 | 24647542 | |
| Pubmed | Autosomal Dominant Sleep-Related Hypermotor (Hyperkinetic) Epilepsy | 8.02e-04 | 10 | 149 | 2 | 20301348 | |
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 8069308 | ||
| Interaction | C2CD4B interactions | 6.49e-07 | 44 | 143 | 6 | int:C2CD4B | |
| Cytoband | 5q33.1 | 8.25e-05 | 26 | 149 | 3 | 5q33.1 | |
| Cytoband | 6q14 | 2.17e-04 | 7 | 149 | 2 | 6q14 | |
| Cytoband | 9q34.11 | 6.97e-04 | 53 | 149 | 3 | 9q34.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 7.07e-04 | 325 | 149 | 6 | chr9q34 | |
| GeneFamily | Fibronectin type III domain containing | 2.92e-04 | 160 | 102 | 6 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.02e-04 | 161 | 102 | 6 | 593 | |
| GeneFamily | Solute carriers | SLC26A2 SLC38A4 SLCO3A1 SLC22A24 SLC4A3 SLC26A1 SLC36A2 SLC36A3 SLC38A8 | 3.96e-04 | 395 | 102 | 9 | 752 |
| GeneFamily | ATPases Ca2+ transporting | 1.11e-03 | 9 | 102 | 2 | 1209 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.11e-03 | 9 | 102 | 2 | 1223 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 3.15e-03 | 15 | 102 | 2 | 26 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 3.59e-03 | 16 | 102 | 2 | 173 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.73e-07 | 180 | 149 | 8 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-06 | 176 | 149 | 7 | 437cfc5e06416bb0fc76d1f9dc106f74e279e880 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-06 | 184 | 149 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.38e-06 | 188 | 149 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.38e-06 | 188 | 149 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 191 | 149 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.75e-06 | 191 | 149 | 7 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 191 | 149 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-06 | 191 | 149 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.16e-06 | 194 | 149 | 7 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 195 | 149 | 7 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.76e-06 | 198 | 149 | 7 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.92e-06 | 199 | 149 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.08e-06 | 200 | 149 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.08e-06 | 200 | 149 | 7 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.08e-06 | 200 | 149 | 7 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 143 | 149 | 6 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.77e-06 | 143 | 149 | 6 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.03e-05 | 147 | 149 | 6 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-epithelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 151 | 149 | 6 | 0de76acd1b204345dce7f33be2a1ed9fbe9e6da0 | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 151 | 149 | 6 | 20b9c8fb966c5d62ff909cc4a4616b109b78cdca | |
| ToppCell | facs-Aorta-Heart-3m-Epithelial|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 151 | 149 | 6 | bee48137d1f5f27a24571a59c835284651d38538 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 152 | 149 | 6 | 87a7116d0064a6051bdf28ce1e48bfc168273e66 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 153 | 149 | 6 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 153 | 149 | 6 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-05 | 153 | 149 | 6 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 164 | 149 | 6 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-05 | 164 | 149 | 6 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | Club_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-05 | 164 | 149 | 6 | 4e25e6362ef793b08de2f4d1dccb6b1fc9c072a5 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 166 | 149 | 6 | 6a6ed5c7a43fee9a8a9be42dfa99303815b8e8ef | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.12e-05 | 167 | 149 | 6 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-05 | 169 | 149 | 6 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.42e-05 | 171 | 149 | 6 | c4a919fe3d56ae6df2fcab6686abacc10befc053 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 171 | 149 | 6 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 172 | 149 | 6 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 172 | 149 | 6 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.58e-05 | 173 | 149 | 6 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.67e-05 | 174 | 149 | 6 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-05 | 174 | 149 | 6 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 175 | 149 | 6 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 175 | 149 | 6 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-SMG_basal_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.84e-05 | 176 | 149 | 6 | 045b12c90f7dd49a9778dadcdf8f18125b380531 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.84e-05 | 176 | 149 | 6 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 177 | 149 | 6 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 179 | 149 | 6 | b44e2d53b82c3c141bfc6539054b19708200a0d9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 180 | 149 | 6 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 180 | 149 | 6 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-05 | 182 | 149 | 6 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-05 | 182 | 149 | 6 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.43e-05 | 182 | 149 | 6 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-05 | 182 | 149 | 6 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.54e-05 | 183 | 149 | 6 | 547b1fb9f9940cfc8d6e351d96acc0da44def57e | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.76e-05 | 185 | 149 | 6 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.99e-05 | 187 | 149 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 187 | 149 | 6 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-05 | 187 | 149 | 6 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | 11.5-Airway-Mesenchymal-Pericyte|Airway / Age, Tissue, Lineage and Cell class | 4.11e-05 | 188 | 149 | 6 | 916971d8660fd20f616346953874e89d2cd13e88 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.11e-05 | 188 | 149 | 6 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.23e-05 | 189 | 149 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Adult-Epithelial-club_cell|Adult / Lineage, Cell type, age group and donor | 4.36e-05 | 190 | 149 | 6 | 756bff697d30aec56c0ebfca94295f084a15bf37 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.49e-05 | 191 | 149 | 6 | 2feab42ac6d29fa4eac78f3f78a5f8aa0a559523 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.49e-05 | 191 | 149 | 6 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 192 | 149 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 192 | 149 | 6 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.62e-05 | 192 | 149 | 6 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 193 | 149 | 6 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.90e-05 | 194 | 149 | 6 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.04e-05 | 195 | 149 | 6 | 9168267a799bbd4111b1227754ab8173ac1a4714 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.18e-05 | 196 | 149 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 5.33e-05 | 197 | 149 | 6 | 67f19dd30adb03300f04219d0295bc1c1788f626 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.33e-05 | 197 | 149 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.48e-05 | 198 | 149 | 6 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.48e-05 | 198 | 149 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.48e-05 | 198 | 149 | 6 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.64e-05 | 199 | 149 | 6 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.64e-05 | 199 | 149 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.64e-05 | 199 | 149 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.64e-05 | 199 | 149 | 6 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-05 | 200 | 149 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 5.80e-05 | 200 | 149 | 6 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-05 | 200 | 149 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 135 | 149 | 5 | 99e7ac9b1139fe4ff036f6f048a8f1cc514c1fb9 | |
| ToppCell | facs-Heart-RV-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 135 | 149 | 5 | 1fe684ed5913ae757ad6befbbe12d1bee481dd12 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-9|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.50e-04 | 150 | 149 | 5 | d9931507257c64ead4a53786e6822f51962c6015 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 80 | 149 | 4 | 54f520cca126810510479fbeade2e3f66fb5dd1b | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Chrm2_(Cerebellum_basket_cells_4)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.50e-04 | 80 | 149 | 4 | ce38ea123853a1e1082a033fb779b63ea440661d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-04 | 152 | 149 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.64e-04 | 153 | 149 | 5 | 9c6fce56300ba5053efda59a438d63a808c497c0 | |
| ToppCell | Club_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.64e-04 | 153 | 149 | 5 | 77030b0e033f3635b1bbe7552a28c074ea7bb106 | |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.89e-06 | 197 | 148 | 9 | 3899_UP | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 6.39e-06 | 199 | 148 | 9 | 7250_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; HL60; HT_HG-U133A | 6.66e-06 | 200 | 148 | 9 | 3044_UP | |
| Drug | NASN | 3.12e-05 | 10 | 148 | 3 | CID000000184 | |
| Drug | vinblastine | 3.40e-05 | 189 | 148 | 8 | CID000013342 | |
| Drug | Tolazoline hydrochloride [59-97-2]; Down 200; 20.4uM; PC3; HT_HG-U133A | 4.10e-05 | 194 | 148 | 8 | 4262_DN | |
| Drug | 2,5-DNP | 4.20e-05 | 2 | 148 | 2 | CID000009492 | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.25e-05 | 195 | 148 | 8 | 4424_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 5438_DN | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 1508_UP | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; HL60; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 2733_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 2641_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 1486_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 3859_UP | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; HL60; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 2333_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; PC3; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 3722_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 2725_UP | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; HL60; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 2683_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; PC3; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 7297_UP | |
| Drug | Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 1702_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 5995_UP | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 148 | 8 | 2134_UP | |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 5.08e-05 | 200 | 148 | 8 | 2148_UP | |
| Disease | four-jointed box protein 1 measurement | 7.07e-05 | 3 | 144 | 2 | EFO_0801605 | |
| Disease | Autosomal dominant nocturnal frontal lobe epilepsy | 1.41e-04 | 4 | 144 | 2 | cv:C3696898 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 2.59e-04 | 63 | 144 | 4 | EFO_0001645, EFO_0004792 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 3.50e-04 | 6 | 144 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.68e-04 | 69 | 144 | 4 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | angina pectoris | 3.79e-04 | 125 | 144 | 5 | EFO_0003913 | |
| Disease | tissue plasminogen activator measurement, coronary artery disease | 4.10e-04 | 71 | 144 | 4 | EFO_0001645, EFO_0004791 | |
| Disease | LDL cholesterol change measurement | 4.89e-04 | 7 | 144 | 2 | EFO_0007804 | |
| Disease | X-24494 measurement | 4.89e-04 | 7 | 144 | 2 | EFO_0800889 | |
| Disease | Autosomal Dominant Nocturnal Frontal Lobe Epilepsy | 4.89e-04 | 7 | 144 | 2 | C3696898 | |
| Disease | Disproportionate short stature | 5.58e-04 | 77 | 144 | 4 | C0878659 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 6.50e-04 | 8 | 144 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | coronary artery disease | NBEAL1 DYNC2H1 BCAS3 TENT5A APOB ITPK1 DOCK5 CELSR2 CASTOR1 PTPRJ TMEM132D SCAF11 BSN PCCB SMAD2 | 7.62e-04 | 1194 | 144 | 15 | EFO_0001645 |
| Disease | cataract (implicated_via_orthology) | 8.47e-04 | 38 | 144 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | triglycerides in large LDL measurement | 1.22e-03 | 43 | 144 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.22e-03 | 43 | 144 | 3 | EFO_0022254 | |
| Disease | response to ondansetron, QT interval | 1.26e-03 | 11 | 144 | 2 | EFO_0004682, EFO_0020997 | |
| Disease | glutamine measurement | 1.33e-03 | 97 | 144 | 4 | EFO_0009768 | |
| Disease | total lipids in very small VLDL measurement | 1.39e-03 | 45 | 144 | 3 | EFO_0022156 | |
| Disease | Heart Diseases | 1.48e-03 | 46 | 144 | 3 | C0018799 | |
| Disease | 11beta-hydroxyandrosterone glucuronide measurement | 1.51e-03 | 12 | 144 | 2 | EFO_0800573 | |
| Disease | free cholesterol in very small VLDL measurement | 1.58e-03 | 47 | 144 | 3 | EFO_0022275 | |
| Disease | myocardial infarction | 1.71e-03 | 350 | 144 | 7 | EFO_0000612 | |
| Disease | Osteogenesis Imperfecta | 1.78e-03 | 13 | 144 | 2 | C0029434 | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 1.78e-03 | 13 | 144 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 1.78e-03 | 13 | 144 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.89e-03 | 50 | 144 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 2.00e-03 | 51 | 144 | 3 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 2.00e-03 | 51 | 144 | 3 | EFO_0022300 | |
| Disease | cholesterol to total lipids in small HDL percentage | 2.00e-03 | 51 | 144 | 3 | EFO_0022240 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 2.07e-03 | 14 | 144 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | chronic obstructive pulmonary disease | 2.09e-03 | 688 | 144 | 10 | EFO_0000341 | |
| Disease | coronary artery disease, factor VII measurement | 2.18e-03 | 111 | 144 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.23e-03 | 53 | 144 | 3 | EFO_0022286 | |
| Disease | factor VIII measurement, coronary artery disease | 2.32e-03 | 113 | 144 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Malignant neoplasm of breast | CTU2 DYNC2H1 OBSCN XDH PANX2 CNTN6 SETD2 MIA2 SURF1 ZFYVE26 VPS13B NOTCH3 HDLBP | 2.38e-03 | 1074 | 144 | 13 | C0006142 |
| Disease | Hypertriglyceridemia | 2.38e-03 | 15 | 144 | 2 | C0020557 | |
| Disease | response to statin, LDL cholesterol change measurement | 2.38e-03 | 15 | 144 | 2 | EFO_0007804, GO_0036273 | |
| Disease | factor XI measurement, coronary artery disease | 2.47e-03 | 115 | 144 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | triglycerides in LDL measurement | 2.61e-03 | 56 | 144 | 3 | EFO_0022320 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 2.71e-03 | 16 | 144 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | 4-acetamidobutanoate measurement | 2.71e-03 | 16 | 144 | 2 | EFO_0021003 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.71e-03 | 118 | 144 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | FEV/FEC ratio | DSP BCAS3 MTFP1 NR3C1 ADCY3 NPLOC4 ITPK1 FREM2 KCNQ5 CSPG4 GSTCD GM2A TOP2B HDLBP | 2.80e-03 | 1228 | 144 | 14 | EFO_0004713 |
| Disease | triglycerides in IDL measurement | 2.89e-03 | 58 | 144 | 3 | EFO_0022149 | |
| Disease | triglycerides to total lipids in small LDL percentage | 3.03e-03 | 59 | 144 | 3 | EFO_0022337 | |
| Disease | phospholipids in VLDL measurement | 3.03e-03 | 59 | 144 | 3 | EFO_0022301 | |
| Disease | alpha-L-iduronidase measurement | 3.07e-03 | 17 | 144 | 2 | EFO_0020139 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.07e-03 | 17 | 144 | 2 | EFO_0022232 | |
| Disease | total lipids in VLDL measurement | 3.18e-03 | 60 | 144 | 3 | EFO_0022314 | |
| Disease | free cholesterol in VLDL measurement | 3.33e-03 | 61 | 144 | 3 | EFO_0022276 | |
| Disease | nephrotic syndrome (is_marker_for) | 3.44e-03 | 18 | 144 | 2 | DOID:1184 (is_marker_for) | |
| Disease | parahippocampal gyrus volume measurement | 3.44e-03 | 18 | 144 | 2 | EFO_0010318 | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 3.44e-03 | 18 | 144 | 2 | EFO_0008317, EFO_0008589 | |
| Disease | triglycerides in medium LDL measurement | 3.49e-03 | 62 | 144 | 3 | EFO_0022322 | |
| Disease | creatinine measurement | USP45 BCAS3 OBSCN PLXNB2 NPLOC4 ITPK1 TBC1D8 CELSR2 LRIG1 PTPRJ CSPG4 BSN | 3.58e-03 | 995 | 144 | 12 | EFO_0004518 |
| Disease | urolithiasis | 3.65e-03 | 63 | 144 | 3 | MONDO_0024647 | |
| Disease | triglycerides to total lipids in IDL percentage | 3.65e-03 | 63 | 144 | 3 | EFO_0022329 | |
| Disease | serum alanine aminotransferase measurement | BTBD8 STAP2 XDH APOB PLXNB2 TBC1D8 CELSR2 PTPRJ PATJ PCCB MX1 | 3.66e-03 | 869 | 144 | 11 | EFO_0004735 |
| Disease | cystatin C measurement | 3.69e-03 | 402 | 144 | 7 | EFO_0004617 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.83e-03 | 19 | 144 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.83e-03 | 19 | 144 | 2 | C1333991 | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 3.83e-03 | 19 | 144 | 2 | EFO_0802076 | |
| Disease | etiocholanolone glucuronide measurement | 3.83e-03 | 19 | 144 | 2 | EFO_0800362 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.83e-03 | 19 | 144 | 2 | C2936783 | |
| Disease | retinal vasculature measurement | 3.98e-03 | 517 | 144 | 8 | EFO_0010554 | |
| Disease | triglycerides in small LDL measurement | 3.99e-03 | 65 | 144 | 3 | EFO_0022323 | |
| Disease | cholesterol in large VLDL measurement | 3.99e-03 | 65 | 144 | 3 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 3.99e-03 | 65 | 144 | 3 | EFO_0022230 | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 4.24e-03 | 20 | 144 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | total lipids in small VLDL | 4.34e-03 | 67 | 144 | 3 | EFO_0022148 | |
| Disease | total lipids in large VLDL | 4.34e-03 | 67 | 144 | 3 | EFO_0022175 | |
| Disease | venous thromboembolism, fibrinogen measurement | 4.34e-03 | 67 | 144 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | free cholesterol in large VLDL measurement | 4.52e-03 | 68 | 144 | 3 | EFO_0022265 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 4.67e-03 | 21 | 144 | 2 | EFO_0022246 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVAIPLPARSLLVLT | 231 | Q9NXW9 | |
| VLEPRVLLTELQPDT | 496 | P21709 | |
| LITEIIPSTSLVIPL | 291 | P43681 | |
| LLESVLEVPVPVRFL | 541 | P48751 | |
| IVLEVFPSSEALRPL | 361 | Q8TDL5 | |
| DRTTPIIPLVDELPV | 376 | P13611 | |
| GVLVELEVLPAAIPL | 1346 | Q6UVK1 | |
| PVFRILTLEPTALTI | 496 | O00481 | |
| PETLPAIATTLIDVL | 191 | Q8WTX7 | |
| PPEEVVRKALDVITI | 426 | Q4VNC1 | |
| VRKALDVITIAVPPA | 431 | Q4VNC1 | |
| EIIPSTSLVIPLIGE | 316 | Q15822 | |
| PDLETTVILPESVFR | 2196 | Q9HCU4 | |
| PIASTLPELVQRLVT | 321 | Q13561 | |
| RSPLVPGIITVIDTE | 311 | Q9H6U6 | |
| LRSQVPPVLDVRTLL | 666 | Q8IWY9 | |
| VLFLVTVLLPSLPAE | 6 | P16562 | |
| VETLIETPLGIRPLT | 251 | Q6P1M9 | |
| LVVAVPEGLPLAVTI | 451 | Q01814 | |
| IPEGLPIVVTVTLAL | 306 | P98194 | |
| ASRPILEPLTVEVLS | 771 | Q8TE58 | |
| LITIIDVIPGRLEIT | 1896 | Q6ZS30 | |
| VTVLPPEAITILEAE | 186 | O95072 | |
| DIPAAILFTIVVPLL | 271 | Q8NHB8 | |
| LPSALPAELARVIVL | 186 | Q8N3Y3 | |
| PLLRLVAEVEESPET | 266 | P35236 | |
| IPIVLPVSAEDKTRL | 296 | O95340 | |
| ELQALLPEPLVSITV | 536 | Q6ZVH7 | |
| IKVITEPIPVSDLRV | 201 | Q12913 | |
| VERLDIPLPIIALIV | 276 | Q7Z418 | |
| APLDVVSVLIPLLEN | 406 | Q9NU22 | |
| TIVLDPLPAIRTLLD | 91 | Q13572 | |
| TLTVLETPSLVVPLE | 686 | Q96JA1 | |
| RIIVELVEFISPKTP | 436 | Q96IV0 | |
| NLVSPITLLPEAEIL | 651 | Q3T906 | |
| SVVPIEVLPTVLLDE | 111 | Q8N201 | |
| VLTPPVILGDTEELV | 2846 | Q8NDA2 | |
| PLPSVVRAVAEEEVL | 3946 | Q8NDA2 | |
| LEKALETIPITPVER | 3986 | Q2LD37 | |
| VEDLTPPLKTVIRAI | 511 | Q9NR82 | |
| TVLIIVIPVDDETPR | 1291 | Q5SZK8 | |
| VDLRTAVKPTPIILT | 1666 | Q9UPA5 | |
| TRVSDVPLSLILPLV | 1191 | O15031 | |
| PPLEITVTEEQRRLL | 1261 | Q9UHC1 | |
| APVRISITLVSVPLI | 161 | Q96KR6 | |
| RPLPVEYLIIDITTT | 441 | Q8TAT6 | |
| PEPIQALETLIVDLV | 66 | Q8IVU3 | |
| GVLVLTVLLPPEELL | 1511 | Q9UM47 | |
| TVLEVRTPVLEQLPV | 1696 | P13942 | |
| VTATIERILQELPPL | 31 | Q6ZV70 | |
| LLTIPIIIHPIDRSV | 131 | Q9UDX5 | |
| IPTIIRRDDPSIIPI | 361 | Q6X4W1 | |
| PQLTPTLVSLLEVIE | 526 | P04150 | |
| LLVPLALEIDPTVQR | 101 | Q9NSB4 | |
| EDLTTLLPRVVPVEP | 201 | Q02509 | |
| VTPPELVDLVITELG | 491 | Q9UI10 | |
| RLPLPVVTEEFIEAL | 336 | Q6R327 | |
| DIPAAILFTIVVPLL | 271 | Q8NHB7 | |
| LLVTEELPRPSLVAL | 121 | Q8IYS5 | |
| RLVVSDIPVVLTRPL | 2461 | Q5VST9 | |
| DRLVPELDTIVPLES | 296 | P05166 | |
| VFSDRPRVPLISIVT | 146 | Q7Z449 | |
| IPSEKLSRIVELIEP | 2091 | Q9P2D7 | |
| ETLEIEPILIIISPG | 3716 | Q8NCM8 | |
| VPLLLSEPINIIDAL | 2026 | P04114 | |
| VIIPELVLPNREVAS | 936 | Q9BYE9 | |
| PIIVLPLKSSISVEV | 401 | O75054 | |
| RTLLIANETLRIPVP | 41 | P05113 | |
| TLIPEAELRKATIPI | 1096 | Q92608 | |
| VGPILEVTLTPEVEL | 1106 | Q9H7D0 | |
| LELEPALPAESVTRV | 256 | Q96CD0 | |
| LVSITVRIPVSRPIL | 196 | Q96LA6 | |
| PVPRTLTSILECLII | 311 | Q5XKL5 | |
| PVTVTELVDSGILRP | 2216 | P15924 | |
| LVPRLVLTVSAPAEV | 21 | Q9H9V9 | |
| VCVPLITLTDVDPLV | 186 | Q00597 | |
| ITLPLSLSPIVIISV | 181 | O60266 | |
| ELLRTKASVPVVAPV | 691 | Q9UQ52 | |
| LEIEHIPITLPIIAS | 91 | Q6P1S2 | |
| VILREIPETTPIEEV | 201 | Q71RC2 | |
| IPIREVLTPESDISI | 261 | Q17RN3 | |
| IAVERVISVEPLLPR | 1006 | Q9ULL0 | |
| LFIEDPSPAISILVL | 1686 | Q8IWT3 | |
| IAPDVTEKLREPLVV | 546 | Q86VF2 | |
| AESPLPAVVLAILAR | 26 | Q5T4B2 | |
| PVPEIRRVALDSLVL | 516 | Q14147 | |
| RILIVVPEIFLPIED | 846 | Q9NQ36 | |
| EVLPLISSVLPRTIF | 256 | Q99590 | |
| SLTPDLTEVLVIPKR | 2926 | Q6ZTR5 | |
| VEIQIISRQELPPIV | 71 | Q8NEC7 | |
| VVALEEVFSLPPSVL | 146 | Q2VPK5 | |
| VVRNALLTAPIPILT | 156 | Q8NGH5 | |
| DRVVTIGTVLVPILL | 51 | Q96RD6 | |
| VLSRQEVPLATLEPL | 256 | Q99574 | |
| ISLIPENLPEITVAV | 351 | Q9Y5E3 | |
| SPIVILTERVVAALP | 621 | Q96PC5 | |
| VPQPDSLDSLIVLIL | 341 | A6NKG5 | |
| AVIRSLTLEPDPIIV | 46 | P17900 | |
| VVELRVPTDLTLLPG | 116 | Q9UGK3 | |
| VVQSLIRVIPLEDPL | 141 | Q96DX4 | |
| VDLVLELPPTSILRV | 76 | A6NEV1 | |
| PPVFIISISLAELAV | 71 | Q9NX52 | |
| DEVRAIIPRVPSLSV | 191 | P78345 | |
| LEETEPVVIPRDSLL | 1346 | Q02880 | |
| PSVIILIRTVSPELK | 556 | Q9UIG8 | |
| VPRLPLQIEVSDTEL | 521 | Q14C87 | |
| ILAVPVILLLPETRD | 506 | Q8N4F4 | |
| LVEILIPDVLRPIPS | 691 | P22670 | |
| EAIPLERFLVPIESI | 256 | Q14249 | |
| VDLVLEPAPTSILRV | 76 | Q6ZRT6 | |
| TALALIIPPLLEVTT | 416 | Q495M3 | |
| TVPLRRISENELVEP | 461 | Q9Y252 | |
| IEELRVPSLVPQERS | 846 | Q9UL54 | |
| IAELESRVLAEPVPL | 91 | Q15526 | |
| VAVTLTVPIVLFPIR | 421 | Q969I6 | |
| LSVLVILPLSAPREI | 156 | A6NNN8 | |
| QPREILTLTPILDIR | 176 | Q495N2 | |
| VIPTLLREAPFSSVI | 46 | Q53RT3 | |
| AVLLPVRVDSATIPR | 46 | Q9UBN6 | |
| VVPTSVIARVLEKPE | 226 | Q5JTD0 | |
| AATPVPIVEKRSEII | 3026 | A4UGR9 | |
| LVTAILEAPVTEPRF | 181 | Q8N1B4 | |
| LVLPSSRIEVLPVDT | 691 | Q92738 | |
| PFIDISLPIIEERVS | 376 | Q70EL2 | |
| LTVYRPTVIPILEEP | 211 | Q9HBT7 | |
| IDPASTVIIIRSLVP | 721 | O75970 | |
| REEVILSPVPSVLKL | 386 | Q4G0A6 | |
| PLPTELLVIVVATLV | 291 | Q9H2B4 | |
| APIPIELVVVVAATL | 331 | P50443 | |
| PLDPTRSVIVIRSLV | 706 | Q8NI35 | |
| PPVLVPRHTEILTEL | 176 | Q15796 | |
| LPEVSEVAVPEVRLP | 556 | Q9BXM0 | |
| NVLRVVIPEVSILPE | 801 | O95759 | |
| VRSEITQPDRDIPLV | 426 | Q6IQ55 | |
| SLLRAIPPIPDEVVV | 126 | A0A1W2PR48 | |
| ISVIELPLPSESVDI | 356 | Q9BTF0 | |
| LLQRLTTVISPPVDV | 596 | Q5SRE5 | |
| TLLSPEEILLSIEIP | 396 | P47989 | |
| LEVTDVLTDRPPPII | 406 | Q9HCK4 | |
| VAVLQESISLPLEIP | 31 | Q96A28 | |
| RPIESLSLIVAVIPD | 76 | Q9BQ87 | |
| VDVAVRSLKEPPIII | 231 | Q9BYW2 | |
| VAEAIPRIPRLSLTI | 1511 | Q7Z4N2 | |
| NPTLVEVLEGVVRLP | 456 | Q9Y5L0 | |
| PSLLLRVEPLDEVTT | 3311 | Q7Z7G8 | |
| EVIPQVSLVPTLALL | 316 | Q8TEQ8 | |
| PLPLAVLLIRVVTSS | 406 | Q6NXT6 | |
| ALEALVPVTIEVEVP | 966 | Q00341 | |
| PTLELQPSLIVKVVR | 91 | Q96IP4 | |
| TALVEPTAPLREVLE | 951 | Q68DK2 | |
| EEALLSVLPTIRVPK | 6 | P45974 | |
| VPDLTLIDLPGITRV | 171 | P20591 |